Global Lipids Active Pharmaceutical Ingredient Market Highlighting Regional Reve

Posted by Arslan on December 24th, 2018

Growing prevalence of cardiovascular diseases, neurological diseases, cancer and other chronic diseases are expected to drive the growth of Lipids Active Pharmaceutical Ingredient Market. In addition, rising demand for the fast-acting and effective drugs coupled with development of advanced drug manufacturing facilities have been fuelling the growth of lipids active pharmaceutical ingredient market. Pharmaceutical companies are likely to eye on developing countries such as Brazil, India and China got outsourcing of lipids active pharmaceutical ingredient, thereby providing growth opportunities for APAC lipids active pharmaceutical ingredient market. Trend of outsourcing lipids active pharmaceutical ingredient is anticipated top continue in the forthcoming years.

Rapidly increasing adoption of the quality standards in the manufacturing of lipids active pharmaceutical ingredient such as GMP (Good Manufacturing Practices), cGMP (current GMP) and ICH (International Conference on Harmonization) has helped in improving safety standards. However, patent expirations of lipids active pharmaceutical ingredient has posed significant challenges for pharmaceutical companies with regards to revenue growth. Lipids active pharmaceutical ingredient industry is anticipated to face challenges such as improving process design by catering to quality standards without compromising on profitability, reducing development cost and time. This in turn is expected to hamper the supply of lipids active pharmaceutical ingredient on a larger basis.

Active pharmaceutical ingredients are specific parts of drugs that produce the effects and are responsible for the actual action of a drug. Some drugs have multiple active ingredients to treat different symptoms. Traditionally, lipids are used as excipients for the production of drugs and cosmetic products, but some potential lipids are used as active pharmaceutical ingredients. Lipids have a broad spectrum of activity and also, have low toxicity, which marks them as promising active pharmaceutical ingredients. However, currently, only a few products available in the market have lipids as the active pharmaceutical ingredients. Extensive research is underway to develop drugs that have lipids as active pharmaceutical ingredients. The main focus of these research activities is to produce the more efficient drugs to treat cardiovascular and inflammatory diseases.   The rise in research and development by several manufacturing companies to produce lipid active pharmaceutical ingredients for the treatment of cardiovascular diseases and inflammatory diseases will propel the growth of this market. Moreover, the rise in use of specialty medicine to treat diseases and increased healthcare expenditure are also responsible for the robust growth of the lipids active pharmaceutical ingredients market. Increased adoption of branded generic and generic drugs in the Asia-Pacific region will also lead to the exponential growth of the lipids active pharmaceutical ingredients market over the forecast period. On the other hand, the high regulatory scenario by FDA for the approval of drugs having lipids active pharmaceutical ingredients will limit the growth of this market to some extent. Lipids are traditionally used as excipients for the production of drugs, which also deters the growth of the lipids active pharmaceutical ingredients market.

Request Full Report with TOC: https://www.factmr.com/report/962/lipids-active-pharmaceutical-ingredient-market

The global market for lipids active pharmaceutical ingredients is expected to witness moderate growth over the forecast period due to the high focus of leading manufacturers towards producing drugs with lipids active pharmaceutical ingredients. The outsourcing of lipids active pharmaceutical ingredients can potentially improve operational efficiencies throughout the value chain. By API type, simple lipids will gain more traction in the lipids active pharmaceutical ingredient market. Leading manufacturers are focusing on partnerships with contract research organizations to develop lipids active pharmaceutical ingredients. A number of growing partnerships, mergers & acquisitions, partnerships, strategic alliances, joint ventures and various other business deals are further strengthening the market.

Geographically, the global lipids active pharmaceutical ingredient market can be segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). Asia-Pacific is expected to be the dominant market in the global lipids active pharmaceutical ingredient market, owing to the high number of API manufacturers in these regions. India and China are the major marketplaces for the lipids active pharmaceutical ingredient market in Asia-Pacific excluding Japan. Europe is expected to hold the second largest share in the global lipids active pharmaceutical ingredient market throughout the forecast period, followed by Latin America and Middle East and Africa.   

The global market for lipids active pharmaceutical ingredients is highly fragmented. Examples of some of the key players operating in the global lipids active pharmaceutical ingredient market are CordenPharma International, Avanti Polar Lipids, VAV Life Sciences, Sancilio & Company Inc., Cayman Chemical, Cerbios-Pharma SA, Merck KGaA, Esperion Therapeutics, Inc.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.